The dsRNA protein kinase PKR: virus and cell control.

The IFN-induced double-stranded RNA-dependent protein kinase (PKR) is one of the four mammalian serine-threonine kinases (the three others being HRI, GCN2 and PERK) that phosphorylate the eIF2 alpha translation initiation factor, in response to stress signals, mainly as a result of viral infections. eIF2 alpha phosphorylation results in arrest of translation of both cellular and viral mRNAs, an efficient way to inhibit virus replication. The particularity of PKR is to activate by binding to dsRNA through two N terminal dsRNA binding motifs (dsRBM). PKR activation during a viral infection represents a threat for several viruses, which have therefore evolved to express PKR inhibitors, such as the Vaccinia E3L and K3L proteins. The function of PKR can also be regulated by cellular proteins, either positively (RAX/PACT; Mda7) or negatively (p58IPK, TRBP, nucleophosmin, Hsp90/70). PKR can provoke apoptosis, in part through its ability to control protein translation, but the situation appears to be more complex, as NF-kappaB, ATF-3 and p53 have also been implicated. PKR-induced apoptosis involves mainly the FADD/caspase 8 pathway, while the mitochondrial APAF/caspase 9 pathway is also engaged. As a consequence of the effects of PKR on translation, transcription and apoptosis, PKR can function to control cell growth and cell differentiation, and its activity can be controlled by the action of several oncogenes.

[1]  R. Jackson,et al.  Phosphorylation of initiation factor eIF-2 and the control of reticulocyte protein synthesis , 1977, Cell.

[2]  B. Williams,et al.  Poly(dI·dC)-induced Toll-like Receptor 3 (TLR3)-mediated Activation of NFκB and MAP Kinase Is through an Interleukin-1 Receptor-associated Kinase (IRAK)-independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR* , 2003, The Journal of Biological Chemistry.

[3]  G. Squadrito,et al.  Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long‐lasting response to interferon therapy in patients with HCV‐1b chronic hepatitis? , 2002, Journal of viral hepatitis.

[4]  T. Hunt,et al.  Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Silverman,et al.  Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. , 1994, Science.

[6]  L. Montagnier,et al.  Efficiency of poly(A).poly(U) as an adjuvant. , 1988, Immunology today.

[7]  N. Sonenberg,et al.  The protein kinase PKR: a molecular clock that sequentially activates survival and death programs , 2004, The EMBO journal.

[8]  N. Sonenberg,et al.  IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. , 1995, Oncogene.

[9]  M. W. Taylor,et al.  Effect of Viral Double-Stranded RNA on Mammalian Cells in Culture: Cytotoxicity Under Conditions Preventing Viral Replication and Protein Synthesis , 1973, Journal of virology.

[10]  D. R. Taylor,et al.  Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.

[11]  A. Helenius,et al.  Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells. , 2005, Virology.

[12]  D. Faller,et al.  Endogenous inhibitors of the dsRNA-dependent eIF-2 alpha protein kinase PKR in normal and ras-transformed cells. , 1994, Biochimie.

[13]  I. Kerr,et al.  The (2'-5') oligoadenylate (pppA2'-5'A2'-5'A) synthetase and protein kinase(s) from interferon-treated cells. , 1979, European journal of biochemistry.

[14]  J. Squire,et al.  Localization of the human interferon-induced, ds-RNA activated p68 kinase gene (PRKR) to chromosome 2p21-p22. , 1993, Genomics.

[15]  N. Sonenberg,et al.  Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: A novel translational control mechanism , 1989, Cell.

[16]  T. Mak,et al.  Activation of the dsRNA‐dependent protein kinase, PKR, induces apoptosis through FADD‐mediated death signaling , 1998, The EMBO journal.

[17]  H. Atkins,et al.  Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKR* , 1999, The Journal of Biological Chemistry.

[18]  B. Williams,et al.  The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin , 2000, The EMBO journal.

[19]  M. Green,et al.  c-Myc Is a Major Mediator of the Synergistic Growth Inhibitory Effects of Retinoic Acid and Interferon in Breast Cancer Cells* , 1998, The Journal of Biological Chemistry.

[20]  C. Rivas,et al.  African Swine Fever Virus GeneA179L,a Viral Homologue ofbcl-2, Protects Cells from Programmed Cell Death , 1996 .

[21]  M. Gross,et al.  The Herpes Simplex Virus Type 1 US11 Protein Interacts with Protein Kinase R in Infected Cells and Requires a 30-Amino-Acid Sequence Adjacent to a Kinase Substrate Domain , 2002, Journal of Virology.

[22]  M. Katze,et al.  P52rIPK regulates the molecular cochaperone P58IPK to mediate control of the RNA-dependent protein kinase in response to cytoplasmic stress. , 2002, Biochemistry.

[23]  P. Duesberg,et al.  Double-stranded RNA in Vaccinia Virus Infected Cells , 1969, Nature.

[24]  P. Lengyel,et al.  The interferon system. A bird's eye view of its biochemistry. , 1992, The Journal of biological chemistry.

[25]  M. Esteban,et al.  In vivo regulation of the dsRNA-dependent protein kinase PKR by the cellular glycoprotein p67. , 2000, Biochemistry.

[26]  P. Roberts,et al.  Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. , 2000, Immunity.

[27]  R. Kaufman,et al.  Phosphorylation of Eukaryotic Translation Initiation Factor 2 Mediates Apoptosis in Response to Activation of the Double-stranded RNA-dependent Protein Kinase* , 1998, The Journal of Biological Chemistry.

[28]  Á. Zaballos,et al.  Human Gene Profiling in Response to the Active Protein Kinase, Interferon-induced Serine/threonine Protein Kinase (PKR), in Infected Cells , 2006, Journal of Biological Chemistry.

[29]  S. B. Lee,et al.  Regulated expression of the interferon-induced protein kinase p68 (PKR) by vaccinia virus recombinants inhibits the replication of vesicular stomatitis virus but not that of poliovirus. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[30]  R. Kobayashi,et al.  The Tat Protein of Human Immunodeficiency Virus Type 1 Is a Substrate and Inhibitor of the Interferon-induced, Virally Activated Protein Kinase, PKR* , 1997, The Journal of Biological Chemistry.

[31]  Susana Guerra,et al.  Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L , 2002, Oncogene.

[32]  Ryuji Fukuda,et al.  Mutant Influenza Viruses with a Defective NS1 Protein Cannot Block the Activation of PKR in Infected Cells , 1999, Journal of Virology.

[33]  M. Clemens,et al.  PKR--a protein kinase regulated by double-stranded RNA. , 1997, The international journal of biochemistry & cell biology.

[34]  N Enomoto,et al.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.

[35]  M J Clemens,et al.  Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. , 1993, Nucleic acids research.

[36]  Qing-Rong Liu,et al.  Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. , 1989, Biochemistry.

[37]  B. Williams,et al.  PKR; a sentinel kinase for cellular stress , 1999, Oncogene.

[38]  Ronit Vogt Sionov,et al.  The cellular response to p53: the decision between life and death , 1999, Oncogene.

[39]  N. Enomoto,et al.  Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. , 1995, The Journal of clinical investigation.

[40]  H. Yoon,et al.  Molecular and structural characterization of the domain 2 of hepatitis C virus non-structural protein 5A. , 2006, Molecules and cells.

[41]  K. Hunt,et al.  Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo , 2005, Molecular Cancer Therapeutics.

[42]  Raymond Kaempfer,et al.  Human Interferon-γ mRNA Autoregulates Its Translation through a Pseudoknot that Activates the Interferon-Inducible Protein Kinase PKR , 2002, Cell.

[43]  R. Kaufman,et al.  Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  I. Kerr,et al.  Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment , 1974, Nature.

[45]  S. Der,et al.  A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Katze,et al.  Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  B. Jacobs,et al.  Both Carboxy- and Amino-Terminal Domains of the Vaccinia Virus Interferon Resistance Gene, E3L, Are Required for Pathogenesis in a Mouse Model , 2001, Journal of Virology.

[48]  N. Sonenberg,et al.  Abrogation of translation initiation factor eIF‐2 phosphorylation causes malignant transformation of NIH 3T3 cells. , 1995, The EMBO journal.

[49]  M. Mathews,et al.  The 3'-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR. , 2002, Nucleic acids research.

[50]  B. Berkhout,et al.  Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. , 1991, Science.

[51]  A. Laurent,et al.  Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Esteban,et al.  Activation of NF-κB by the dsRNA-dependent protein kinase, PKR involves the IκB kinase complex , 2000, Oncogene.

[53]  J. Hershey,et al.  Translational control in mammalian cells. , 1991, Annual review of biochemistry.

[54]  G. Stark,et al.  A mutant cell line defective in response to double-stranded RNA and in regulating basal expression of interferon-stimulated genes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  A. Lau,et al.  Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  T. Takizawa,et al.  Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection , 1996, Journal of virology.

[57]  M. Karin,et al.  JNK2 and IKKbeta are required for activating the innate response to viral infection. , 1999, Immunity.

[58]  T. Terada,et al.  Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma. , 2000, Liver.

[59]  J. Howard,et al.  Low TRBP Levels Support an Innate Human Immunodeficiency Virus Type 1 Resistance in Astrocytes by Enhancing the PKR Antiviral Response , 2005, Journal of Virology.

[60]  R. Krug,et al.  Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. , 2006, Virology.

[61]  E M Schwarz,et al.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.

[62]  Michael G. Katze,et al.  Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation , 1998, Molecular and Cellular Biology.

[63]  M. Esteban,et al.  Interferon inhibits Viral Protein Synthesis in L Cells infected with Vaccinia Virus , 1972, Nature.

[64]  Anne Gatignol,et al.  TRBP, a regulator of cellular PKR and HIV‐1 virus expression, interacts with Dicer and functions in RNA silencing , 2005, EMBO reports.

[65]  A. Cuddihy,et al.  The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro , 1999, Oncogene.

[66]  M. Mathews,et al.  Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[67]  J. Langland,et al.  Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells , 1997, Journal of virology.

[68]  A. Hovanessian,et al.  Autophosphorylation of the protein kinase dependent on double-stranded RNA. , 1987, The Journal of biological chemistry.

[69]  M. Katze,et al.  PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon. , 1993, Journal of interferon research.

[70]  R. Rhoads Regulation of eukaryotic protein synthesis by initiation factors. , 1993, The Journal of biological chemistry.

[71]  A. Koromilas,et al.  Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[72]  B. Jacobs,et al.  Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L. , 1997, Virology.

[73]  C. Samuel,et al.  Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. , 1991, Virology.

[74]  M. Katze,et al.  Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.

[75]  M. Lai,et al.  Detection of a Novel Unglycosylated Form of Hepatitis C Virus E2 Envelope Protein That Is Located in the Cytosol and Interacts with PKR , 2002, Journal of Virology.

[76]  A. Hinnebusch,et al.  Binding of Double-stranded RNA to Protein Kinase PKR Is Required for Dimerization and Promotes Critical Autophosphorylation Events in the Activation Loop* , 2001, The Journal of Biological Chemistry.

[77]  Mingli Yang,et al.  RAX, a Cellular Activator for Double-stranded RNA-dependent Protein Kinase during Stress Signaling* , 1999, The Journal of Biological Chemistry.

[78]  J. Sample,et al.  Protection from Interferon-Induced Apoptosis by Epstein-Barr Virus Small RNAs Is Not Mediated by Inhibition of PKR , 2005, Journal of Virology.

[79]  M. Katze,et al.  Molecular Mechanisms Responsible for Malignant Transformation by Regulatory and Catalytic Domain Variants of the Interferon-induced Enzyme RNA-dependent Protein Kinase (*) , 1995, The Journal of Biological Chemistry.

[80]  U. Maitra,et al.  Regulation of GTP hydrolysis prior to ribosomal AUG selection during eukaryotic translation initiation , 2005, The EMBO journal.

[81]  Amer A. Beg,et al.  Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon , 2000, Journal of Virology.

[82]  S. Goodbourn,et al.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. , 2000, The Journal of general virology.

[83]  P. Romano,et al.  Protein Synthesis and Endoplasmic Reticulum Stress Can Be Modulated by the Hepatitis C Virus Envelope Protein E2 through the Eukaryotic Initiation Factor 2α Kinase PERK , 2003, Journal of Virology.

[84]  E. Domingo,et al.  Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action , 2006, Microbiology and Molecular Biology Reviews.

[85]  S. Zeuzem,et al.  Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa , 1997, Hepatology.

[86]  Rekha C. Patel,et al.  PACT, a Stress-modulated Cellular Activator of Interferon-induced Double-stranded RNA-activated Protein Kinase, PKR* , 2000, The Journal of Biological Chemistry.

[87]  A. Moreau,et al.  Mutations within the Hepatitis C Virus Genotype 1b E2-PePHD Domain Do Not Correlate with Treatment Outcome , 2005, Journal of Clinical Microbiology.

[88]  A. Shahangian,et al.  Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response , 2006, Nature.

[89]  Tsonwin Hai,et al.  The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. , 2001, Gene.

[90]  E. Meurs,et al.  The N-terminus of PKR is responsible for the activation of the NF-kappaB signaling pathway by interacting with the IKK complex. , 2006, Cellular signalling.

[91]  Ł. Kruszyna,et al.  Mutations within protein kinase R-binding domain of NS5A protein of hepatitis C virus (HCV) and specificity of HCV antibodies in pretreatment sera of HCV-chronically infected patients and their effect on the result of treatment. , 2006, Japanese journal of infectious diseases.

[92]  H. Kawasaki,et al.  Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. , 1998, Cancer research.

[93]  S. Kadereit,et al.  Protein kinase PKR is required for platelet‐derived growth factor signaling of c‐fos gene expression via Erks and Stat3 , 2001, The EMBO journal.

[94]  A. Hovanessian The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. , 1989, Journal of interferon research.

[95]  M. Karin,et al.  Double-stranded RNA-dependent Protein Kinase Phosphorylation of the α-Subunit of Eukaryotic Translation Initiation Factor 2 Mediates Apoptosis* , 2006, Journal of Biological Chemistry.

[96]  M. Katze,et al.  Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[97]  David Hawke,et al.  Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. , 2003, Molecular cell.

[98]  D. Harrich,et al.  Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription , 2005, Virology Journal.

[99]  M. Mathews,et al.  Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR , 2000, Oncogene.

[100]  C. D. Krause,et al.  Interferons, interferon‐like cytokines, and their receptors , 2004, Immunological reviews.

[101]  A. Koromilas,et al.  Dominant Negative Function by an Alternatively Spliced Form of the Interferon-inducible Protein Kinase PKR* , 2001, The Journal of Biological Chemistry.

[102]  Jill K Thompson,et al.  Role of IB Ubiquitination in Signal-induced Activation of NF-B in Vivo(*) , 1996, The Journal of Biological Chemistry.

[103]  M. Coffey,et al.  The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus , 1998, The EMBO journal.

[104]  M. Tohyama,et al.  An RNA‐dependent protein kinase is involved in tunicamycin‐induced apoptosis and Alzheimer's disease , 2004, The EMBO journal.

[105]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[106]  M. Serrano,et al.  Antiviral action of the tumor suppressor ARF , 2006, The EMBO journal.

[107]  Paola Fazi,et al.  Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. , 2005, The New England journal of medicine.

[108]  L. Tone,et al.  A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia. , 2005, Blood cells, molecules & diseases.

[109]  P. Lengyel Tumor-suppressor genes: news about the interferon connection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[110]  Tyson V. Sharp,et al.  The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation. , 1998, Virology.

[111]  M. Clemens,et al.  Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. , 1995, Experimental cell research.

[112]  R. M. Marión,et al.  Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. , 1999, Nucleic acids research.

[113]  O. Elroy-Stein,et al.  The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2 , 1992, Journal of virology.

[114]  L. Beretta,et al.  Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein , 2001, Oncogene.

[115]  A. Heller,et al.  Expression of a PKR dominant-negative mutant in myogenic cells interferes with the myogenic process. , 2000, Experimental cell research.

[116]  Arvin C. Dar,et al.  Higher-Order Substrate Recognition of eIF2α by the RNA-Dependent Protein Kinase PKR , 2005, Cell.

[117]  K. Hunt,et al.  Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[118]  Stephen G Swisher,et al.  Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). , 2002, Cancer research.

[119]  I. Mohr,et al.  Identification of a Lytic-Cycle Epstein-Barr Virus Gene Product That Can Regulate PKR Activation , 2003, Journal of Virology.

[120]  O. Jaillon,et al.  Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. , 1998, The Journal of general virology.

[121]  K. Schappert,et al.  Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. , 1992, The EMBO journal.

[122]  R. Kaufman,et al.  Double-Stranded RNA-Activated Protein Kinase (PKR) Is Negatively Regulated by 60S Ribosomal Subunit Protein L18 , 1999, Molecular and Cellular Biology.

[123]  J. Puglisi,et al.  Specific recognition of HIV TAR RNA by the dsRNA binding domains (dsRBD1-dsRBD2) of PKR. , 2006, Journal of molecular biology.

[124]  A. Shatkin,et al.  Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins. , 1997, Virology.

[125]  L. David,et al.  Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR* , 2003, Journal of Biological Chemistry.

[126]  S. B. Lee,et al.  The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. , 1994, Virology.

[127]  P. Moore,et al.  Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53 , 2001, Journal of Virology.

[128]  K. Jeang,et al.  Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA‐dependent protein kinase PKR , 1997, The EMBO journal.

[129]  J. Buchner,et al.  Hsp90 & Co. - a holding for folding. , 1999, Trends in biochemical sciences.

[130]  S. Nanduri,et al.  1H, 13C, 15N Resonance Assignment of the 20 kDa Double Stranded RNA Binding Domain of PKR , 1998, Journal of biomolecular NMR.

[131]  B. Williams,et al.  Cell cycle regulation of the double stranded RNA activated protein kinase, PKR , 1999, Oncogene.

[132]  A. Levitzki,et al.  Activation of dsRNA dependent protein kinase PKR in Karpas299 does not lead to cell death , 2005, Cancer biology & therapy.

[133]  B. Williams,et al.  Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF‐1 and NF‐κB , 1997, The EMBO journal.

[134]  N. Sonenberg,et al.  Double-stranded RNA-dependent Protein Kinase Mediates c-Myc Suppression Induced by Type I Interferons* , 1996, The Journal of Biological Chemistry.

[135]  M. Iordanov,et al.  Two mechanisms of caspase 9 processing in double-stranded RNA- and virus-triggered apoptosis , 2005, Apoptosis.

[136]  H. Nakano,et al.  TRAF Family Proteins Link PKR with NF-κB Activation , 2004, Molecular and Cellular Biology.

[137]  Arnab Ghosh,et al.  Eukaryotic initiation factor 2-associated glycoprotein, p67, shows differential effects on the activity of certain kinases during serum-starved conditions. , 2004, Archives of biochemistry and biophysics.

[138]  M. Katze,et al.  Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR by Vaccinia Virus E3: Role of Complex Formation and the E3 N-Terminal Domain , 1998, Molecular and Cellular Biology.

[139]  W. Fujimoto,et al.  Expression of Double‐Stranded RNA‐Activated Protein Kinase in Keratinocytes and Keratinocytic Neoplasia , 2003, The Journal of dermatology.

[140]  M. Mathews,et al.  Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR , 2002, Oncogene.

[141]  Mikhail Chernov,et al.  Regulation of c‐myc expression by IFN‐γ through Stat1‐dependent and ‐independent pathways , 2000 .

[142]  M. Katze,et al.  The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins , 1994, Molecular and cellular biology.

[143]  E. Paoletti,et al.  Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses. , 1995, Virology.

[144]  B. Williams,et al.  NF-κB Activation by Double-Stranded-RNA-Activated Protein Kinase (PKR) Is Mediated through NF-κB-Inducing Kinase and IκB Kinase , 2000, Molecular and Cellular Biology.

[145]  M. Esteban,et al.  Caspase 9 activation by the dsRNA‐dependent protein kinase, PKR: molecular mechanism and relevance , 2002, FEBS letters.

[146]  M. Esteban,et al.  The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. , 1997, Virology.

[147]  M. Katze,et al.  Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[148]  P. Romano,et al.  Ribosome Targeting of PKR Is Mediated by Two Double-stranded RNA-binding Domains and Facilitates in Vivo Phosphorylation of Eukaryotic Initiation Factor-2* , 1997, The Journal of Biological Chemistry.

[149]  A. Gobl,et al.  Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours. , 1998, European journal of cancer.

[150]  J. Li,et al.  Activation of the dsRNA-dependent kinase. , 1994, Progress in molecular and subcellular biology.

[151]  S. Hasnain,et al.  Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. , 2000, Biochemistry.

[152]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[153]  I. Mohr,et al.  Inhibition of PACT-Mediated Activation of PKR by the Herpes Simplex Virus Type 1 Us11 Protein , 2002, Journal of Virology.

[154]  Tsonwin Hai,et al.  Activating Transcription Factor 3, a Stress-inducible Gene, Suppresses Ras-stimulated Tumorigenesis* , 2006, Journal of Biological Chemistry.

[155]  M. Esteban,et al.  The interferon-induced double-stranded RNA-activated human p68 protein kinase potently inhibits protein synthesis in cultured cells. , 1993, Virology.

[156]  J. Langland,et al.  Reovirus σ3 Protein: dsRNA Binding and Inhibition of RNA-Activated Protein Kinase , 1998 .

[157]  D. Purcell,et al.  Two Dimerization Domains in the Trans-activation Response RNA-binding Protein (TRBP) Individually Reverse the Protein Kinase R Inhibition of HIV-1 Long Terminal Repeat Expression* , 2001, The Journal of Biological Chemistry.

[158]  T. Haneji,et al.  Okadaic acid induces tyrosine phosphorylation of IκBα that mediated by PKR pathway in human osteoblastic MG63 cells , 2005, Molecular and Cellular Biochemistry.

[159]  M. Esteban,et al.  Induction of Apoptosis by Double-Stranded-RNA-Dependent Protein Kinase (PKR) Involves the α Subunit of Eukaryotic Translation Initiation Factor 2 and NF-κB , 1999, Molecular and Cellular Biology.

[160]  A. García-Sastre,et al.  Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein , 2000, Journal of Virology.

[161]  C. Rivas,et al.  Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. , 1998, Virology.

[162]  R. Silverman,et al.  The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis , 1998, Cell Death and Differentiation.

[163]  B. Williams Signal Integration via PKR , 2001, Science's STKE.

[164]  J. Nussbaum,et al.  Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer. , 2003, Cancer letters.

[165]  J. Radosevich,et al.  Interferon-Responsive Protein Kinase (p68) and Proliferating Cell Nuclear Antigen Are Inversely Distributed in Head and Neck Squamous Cell Carcinoma , 1997, Tumor Biology.

[166]  A. Koromilas,et al.  Functional Characterization of pkr Gene Products Expressed in Cells from Mice with a Targeted Deletion of the N terminus or C terminus Domain of PKR* , 2002, The Journal of Biological Chemistry.

[167]  M. Katze,et al.  Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. , 1992, Science.

[168]  A. Hovanessian,et al.  Further characterization of the protein kinase activity mediated by interferon in mouse and human cells. , 1984, The Journal of biological chemistry.

[169]  N. Sonenberg,et al.  The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus , 2000, Journal of Virology.

[170]  O. Donzé,et al.  The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA‐dependent kinase PKR , 2001, The EMBO journal.

[171]  M. Esteban,et al.  Evidence that avian reovirus sigmaA protein is an inhibitor of the double-stranded RNA-dependent protein kinase. , 2003, The Journal of general virology.

[172]  G. Peters,et al.  Modular Structure of PACT: Distinct Domains for Binding and Activating PKR , 2001, Molecular and Cellular Biology.

[173]  M. Esteban,et al.  The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-κB activation , 2001, Oncogene.

[174]  M. Katze,et al.  Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. , 1995, Virology.

[175]  C. Disteche,et al.  Chromosomal assignment of the interferon-inducible double-stranded RNA-dependent protein kinase (PRKR) to human chromosome 2p21-p22 and mouse chromosome 17 E2. , 1993, Genomics.

[176]  O. Elroy-Stein,et al.  Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. , 1993, The Journal of biological chemistry.

[177]  E. Meurs,et al.  PKR Stimulates NF-κB Irrespective of Its Kinase Function by Interacting with the IκB Kinase Complex , 2000, Molecular and Cellular Biology.

[178]  G. Courtois,et al.  Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.

[179]  Adolfo Garcia-Sastre,et al.  Influenza Virus NS1 Protein Counteracts PKR-Mediated Inhibition of Replication , 2000, Journal of Virology.

[180]  R. Kaufman,et al.  Identification and requirement of three ribosome binding domains in dsRNA-dependent protein kinase (PKR). , 1998, Biochemistry.

[181]  G. Bagby,et al.  The Anti-apoptotic Function of Hsp70 in the Interferon-inducible Double-stranded RNA-dependent Protein Kinase-mediated Death Signaling Pathway Requires the Fanconi Anemia Protein, FANCC* , 2002, The Journal of Biological Chemistry.

[182]  O. Haus,et al.  The genes of interferons and interferon-related factors: localization and relationships with chromosome aberrations in cancer. , 2000, Archivum immunologiae et therapiae experimentalis.

[183]  B. Roizman,et al.  The γ134.5 Protein of Herpes Simplex Virus 1 Has the Structural and Functional Attributes of a Protein Phosphatase 1 Regulatory Subunit and Is Present in a High Molecular Weight Complex with the Enzyme in Infected Cells* , 1998, The Journal of Biological Chemistry.

[184]  S. Goodbourn,et al.  Double‐stranded RNA activates binding of NF‐kappa B to an inducible element in the human beta‐interferon promoter. , 1989, The EMBO journal.

[185]  G. Sen,et al.  PACT, a protein activator of the interferon‐induced protein kinase, PKR , 1998, The EMBO journal.

[186]  Arvin C. Dar,et al.  Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition , 2005, Cell.

[187]  K. Endo,et al.  Protein expression of double-stranded RNA-activated protein kinase in thyroid carcinomas: correlations with histologic types, pathologic parameters, and Ki-67 labeling. , 2000, Human pathology.

[188]  W. Blalock,et al.  Serine 18 Phosphorylation of RAX, the PKR Activator, Is Required for PKR Activation and Consequent Translation Inhibition* , 2004, Journal of Biological Chemistry.

[189]  T. Mak,et al.  HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. , 1995, Virology.

[190]  M. Katze,et al.  The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. , 1989, European journal of biochemistry.

[191]  A. Aguzzi,et al.  Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.

[192]  I. Kerr,et al.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.

[193]  M. Clemens Epstein-Barr virus: inhibition of apoptosis as a mechanism of cell transformation. , 2006, The international journal of biochemistry & cell biology.

[194]  A. Yoshimura,et al.  Control of α Subunit of Eukaryotic Translation Initiation Factor 2 (eIF2α) Phosphorylation by the Human Papillomavirus Type 18 E6 Oncoprotein: Implications for eIF2α-Dependent Gene Expression and Cell Death , 2004, Molecular and Cellular Biology.

[195]  M. Katze,et al.  The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[196]  S. Hanash,et al.  Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias. , 1996, Oncogene.

[197]  N. McMillan,et al.  Loss of PKR activity in chronic lymphocytic leukemia , 2004, International journal of cancer.

[198]  P. Pitha,et al.  Latently Expressed Human Herpesvirus 8-Encoded Interferon Regulatory Factor 2 Inhibits Double-Stranded RNA-Activated Protein Kinase , 2001, Journal of Virology.

[199]  Aseem Kumar,et al.  Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[200]  M. Esteban,et al.  The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-α receptors , 2000, Oncogene.

[201]  I. Kerr,et al.  Mechanism of Interferon Action: Inhibition of Viral Messenger Ribonucleic Acid Translation in L-Cell Extracts , 1972, Journal of virology.

[202]  E. Park,et al.  Double‐stranded RNA–activated protein kinase is required for the LPS‐induced activation of STAT1 inflammatory signaling in rat brain glial cells , 2005, Glia.

[203]  R. Hayden,et al.  Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. , 1996, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[204]  V. Pathak,et al.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs , 1989, Molecular and cellular biology.

[205]  A. Cuddihy,et al.  Double-Stranded-RNA-Activated Protein Kinase PKR Enhances Transcriptional Activation by Tumor Suppressor p53 , 1999, Molecular and Cellular Biology.

[206]  C. Rivas,et al.  The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation. , 2003, The Journal of general virology.